Dylan Pillai, M.D., Ph.D
dylan.pillai@ucsf.edu

Mailing Address:
University of California, San Francisco
Division of Infectious Diseases
521 Parnassus Avenue, Room C-443
San Francisco, CA 94143-0654

Office Location:
Clinical Sciences Building - C429

Research Interests:
Entamoeba histolytica; Plasmodium falciparum malaria; molecular and cellular biology

Select Publications:

Pillai DR, KeystoneJS, Sheppard DC, MacLeanJD, MacPherson DW, Kain KCEntamoebahistolytica and Entamoeba dispar: Epidemiology and comparison of diagnostic methods in a setting of non-endemicity. Clin Infect Dis. 29(5): 1315-8, 1999.

Pillai DR, Wan PSK, Yau YCW, Ravdin JI, Kain KC. The cysteine-rich region of the Entamoeba histolytica adherence lectin (170-kDa subunit) is sufficient for high affinity Gal/GalNAc-specific binding in vitro. Infect Immun. 67(8):3836-41, 1999.

Pillai DR, Kain KC. Recent developments in amebiasis: The Gal/GalNAc lectins of Entamoeba histolytica and Entamoeba dispar. Microbes and Infection. 2(14): 1775-83, 2000.

Pillai DR, Labbe AC, Vanisaveth V, Hongvangthong B, Phompida S, Boutha N, Zhong K, Kain KC. Plasmodium falciparum malaria in Lao PDR: Chloroquine treatment outcome and predictive value of molecular markers. J Infect Dis. 183(5):789-95, 2001.

Pillai DR, Hijar G, Montoya Y, Ruebush II TK, Marquino W, Kain KC. The predictive value of mutations in pfmdr1 in mefloquine and mefloquine-artesunate drug therapy against Plasmodium falciparum malaria in Peru. Amer J Trop Med & Hyg. 68(1): 107-110, 2003.

Education and Training:

MD, PhD, University of Toronto, 1994-2002

Internal Medicine Residency, Stanford University Medical Center, 2002-2004

Infectious Diseases Fellow, University of California, San Francisco, 2004- present

Relevant Links:

http://www.mmv.org/pages/page_main.htm

http://derisilab.ucsf.edu

http://pg.photos.yahoo.com/ph/dylan.pillai@sbcglobal.net/album?.dir=/c60f&.src=ph&.tok=ph6iuYCB5JOlz9Fb